The purpose of the paper is to report the clinical outcomes of 4 patients with ruptured abdominal aortic aneurysm (AAA) during (3 patients) or immediately after (1 patient) moderate-severe SARS-CoV-2 infection. We discuss COVID-19-related mechanisms which could impact AAA rupture.
Patients and Methods:
During the period of the pandemic (March 2020—May 2021), we performed surgery in 18 patients with ruptured AAA. Four patients were affected by moderate or severe SARS-CoV-2 infection (in 3 patients the rupture occurred during the infection and in 1 patient 3. months after discharge from the hospital). Two patients underwent open repair and 2 endovascular surgery.
Results:
No postoperative mortality and no major complication occurred. Rapid growth of the AAA in comparison with a previous Duplex scan was evident in all 4 patients.
Conclusions:
Family doctors and vascular surgeons should be aware about the possibility of AAA degeneration in patients with moderate-severe COVID19 infection. The risk is increased by steroid therapy which is essential in more advanced stages of the infection. In this clinical setting, endovascular repair is a valid choice.
BozzaniAAriciVTavazziG, et al. Acute thrombosis of lower limbs arteries in the acute phase and after recovery from COVID19. Ann Surg. 2021;273(4):e159–e160. doi:10.1097/SLA.0000000000004700.
2.
BozzaniAAriciVTavazziG, et al. Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy. Surgery. 2020;168(6):987–992. doi:10.1016/j.surg.2020.09.009.
3.
McGreevyDTHörerTM.Treatment of aortic aneurysms during the COVID-19 pandemic: time to abandon the NICE guidelines. J Endovasc Ther. 2020;27(6):979. doi:10.1177/1526602820948849.
4.
SultanSVeithFJAscherE, et al. NICE guidelines for AAA repair: an enigma. J Endovasc Ther. 2020;27(5):869–870. doi:10.1177/1526602820941163.
5.
KimLGSweetingMJArmerM, et al. Modelling the impact of changes to abdominal aortic aneurysm screening and treatment services in England during the COVID-19 pandemic. PLoS One. 2021;16(6):e0253327. doi:10.1371/journal.pone.0253327.
6.
LiHYanBGaoR, et al. Effectiveness of corticosteroids to treat severe COVID-19: a systematic review and meta-analysis of prospective studies. Int Immunopharmacol. 2021;100:108121. doi:10.1016/j.intimp.2021.108121.
7.
AlsaiedTTremouletAHBurnsJC, et al. Review of cardiac involvement in multisystem inflammatory syndrome in children circulation. Circulation. 2021;143(1):78–88. doi:10.1161/CIRCULATIONAHA.120.049836.
8.
RileyCJTeixeiraP.Development of symptomatic inflammatory aneurysm treated with endovascular repair in coronavirus disease 2019-infected patient. J Vasc Surg Cases Innov Tech. 2021;7(2):193–196. doi:10.1016/j.jvscit.2021.03.003.
BogaertKChristensenKCagliostroM, et al. Contained aortic rupture in a term pregnant patient during the COVID-19 pandemi. BMJ Case Rep. 2020;13(9):e238370. doi:10.1136/bcr-2020-238370.
11.
YammineHBallastJKPoulsenN, et al. Endovascular aortic repair in an asymptomatic COVID-19-positive patient with a symptomatic inflammatory abdominal aortic aneurysm. J Vasc Surg Cases Innov Tech. 2020;6(4):531–533. doi:10.1016/j.jvscit.2020.08.016.
12.
ShihMSwearingenBRheeR.Ruptured abdominal aortic aneurysm treated with endovascular repair in a patient with active COVID-19 infection during the pandemic. Ann Vasc Surg. 2020;66:14–17. doi:10.1016/j.avsg.2020.05.001.
13.
RinaldiLFMarazziGMaroneEM.Endovascular treatment of a ruptured pararenal abdominal aortic aneurysm in a patient with coronavirus disease-2019: suggestions and case report. Ann Vasc Surg. 2020;66:18–23. doi:10.1016/j.avsg.2020.05.011.
14.
XuBLiGGuoJ, et al. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms. J Vasc Surg. 2021. doi:10.1016/j.jvs.2021.01.051.
15.
BorrelliVSterpettiAVColucciaP, et al. Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture. J Surg Res. 2001;100(2):154–160. doi:10.1006/jsre.2001.6231.
16.
CucinaABorrelliVDi CarloA, et al. Thrombin induces production of growth factors from aortic smooth muscle cells. J Surg Res. 1999;82(1):61–66. doi:10.1006/jsre.1998.5514.
17.
ZhanYShangJGuY, et al. Efficacy of corticosteroid in patients with COVID-19: a multi-center retrospective study and meta-analysis. J Med Virol. 2021;93(7):4292–4302.
18.
GuéroultAMKhanFAStatherPW, et al. Long-term outcomes following endovascular aneurysm repair for ruptured abdominal aortic aneurysms. J Endovascther. 2020;27(3):428–435. doi:10.1177/1526602820919901.
19.
SelwayWGStensonKMHoltPJ, et al. Willingness of patients to attend abdominal aortic aneurysm surveillance: the implications of COVID-19 on restarting the National Abdominal Aortic Aneurysm Screening Programme. Br J Surg. 2020;107(13):e646–e647. doi:10.1002/bjs.12059.
20.
SterpettiAVCavallariNAllegrucciP, et al. Seasonal variation in the incidence of ruptured abdominal aortic aneurysm. J R Coll Surg Edinb. 1995;40(1):14–15.
21.
BozzaniAPalliniMAriciV, et al. Re-organization of the vascular surgery department during the acute phase of the COVID19 outbreak: lessons learned and future perspectives. Ann Vasc Surg. 2021;72:191–195. doi:10.1016/j.avsg.2020.12.001.
22.
BozzaniAAriciVTicozzelliG, et al. Endovascular surgery during COVID-19 virus pandemic as a valid alternative to open surgery. Ann Vasc Surg. 2021;71:101–102. doi:10.1016/j.avsg.2020.09.043.
